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RESEARCH ARTICLE
Evaluation of epidemiological data of 541 patients with brucellosis in Siirt, a city in 
south-eastern Anatolia
Güneydoğu Anadolu Bölgesinde bulunan Siirt ilinde 541 bruselloz olgusunun epidemiyolojik 
verilerinin irdelenmesi
Fatih Demircan1, Zafer Mengeloğlu2, Faruk Kılınç3, Affan Denk4 
ÖZET
Amaç: Ülkemiz açısından önem arz eden ve önlenebilir bir 
enfeksiyon olan bruselloz ile ilgili deneyimlerimizi sunarak 
konuyu irdelemek amacıyla 541 bruselloz olgusu değer-
lendirilmiştir.
Yöntemler: Ocak 2006-Aralık 2010 tarihleri arasında yatı-
rılarak takip ve tedavileri yapılan 1210 hasta geriye dönük 
olarak incelenmiş, Rose Bengal pozitif ve Wright aglutinas-
yon testi titresi 1/160 ve üzeri olan 541 bruselloz olgusu 
çalışmaya dahil edilmiştir.
Bulgular: Çalışmamıza alınan 541olgunun %53,6’sı erkek 
%46,4’ü kadın olup, yaş ortalamaları 41,23±2,7 idi. Hem 
erkeklerde hem de kadınlarda brusellozun en sık görüldü-
ğü yaş aralığı 31-50 yaş arası olmuştur. Hematolojik bul-
gulardan hastaların %67’sinde sedimentasyon 20-40 mm/
saat, %53’ünde lökosit sayısı normal aralıkta iken, has-
taların %36’sında lökositoz, %10’unda lökopeni, %8’inde 
trombositopeni bulunmuştur. En sık gözlenen üç semptom 
eklem ağrısı (%90), kas ağrısı (%75) ve halsizlik (%70) ol-
muştur. En sık tutulan sistemler sırasıyla kas iskelet (%28), 
hematolojik (%22) ve gastrointestinal sistemler (%20) ol-
muştur. Kas iskelet sistemi bulgularından sakroileit (%20
), hematolojik bulgulardan anemi (%14) ve gastrointesti-
nal  sistemden  ise  karaciğer  fonksiyon  bozukluğu  (%12) 
en sık raslanan sistemik bulgular olmuştur.  Bu endemik 
hastalığın en çok (%30) gözlemlendiği ay Mayıs olmuştur. 
Olgularımızın %47’sinin bruselloz açısından riskli meslek 
olan tarım ve hayvancılıkla uğraşıyor olması, bruselloz epi-
demiolojisi hakkındaki klasik bilgileri destekler niteliktedir.
Sonuç:  Önleyici  programlara  rağmen  bu  enfeksiyonun 
oranı hala yüksek olup, hem insan sağlığını hem de hay-
vancılık sektörünü etkiler. Bundan dolayı bu yaygın en-
feksiyon hastalığı ile ilgili daha geniş serilerin irdelendiği 
çalışmalara ihtiyaç duyulmaktadır.
Anahtar kelimeler: Bruselloz, enfeksiyöz hastalıklar, en-
demik hastalık, rose bengal, aglütinasyon testleri.
ABSTRACT
Objectives: We intended to examine 541 brucellosis cas-
es by offering our experiences regarding this preventable 
infectious disease that is significant for our country.
Methods: We evaluated 1210 hospitalized patients be-
tween the dates of January 2006 and December 2010 in 
Siirt General Hospital and 541 brucellosis cases were re-
viewed retrospectively. Patients with Rose Bengal plate 
test positive and has Wright agglutination test a titer of 
1:160 or higher were included in this study.
Results: A 53.6% of brucellosis cases were male and 
46.4%  were  female.  The  mean  age  (±SD)  of  patients 
was 41.23±2.7 years. Between the ages 31 and 50 is 
the range brucellosis is most commonly encountered in 
both men and women. Hematological evidence discov-
ered that for 67% of patient’s sedimentation is 20-40 mm/
hour, 53% leukocyte count is in normal range, 36% of pa-
tients had leukocytosis, 10% had leukopenia, and 8% had 
thrombocytopenia. Most common three symptoms were 
joint pain (90%), myalgia (75%) and fatigue (70%). The 
most involved systems were musculoskeletal (28%), he-
matological (22%), and gastrointestinal systems (20%). 
Most commonly encountered systemic findings were sac-
roiliitis (20%), anemia (14%) and liver dysfunction (12%). 
Brucella was observed most commonly is May (30%) in 
Siirt. A 47% of our cases are occupied in agriculture and 
stockbreeding that are risky occupations regarding bru-
cellosis, supports the conventional data regarding brucel-
losis epidemiology.
Conclusion: Despite the campaigns, infection rate is still 
high and it affects both animal industry and human health 
in our country. Data about brucellosis should be validated 
by large multicenter studies. J Clin Exp Invest 2013; 4 (2): 
136-140
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INTRODUCTION
Brucellosis is a worldwide zoonotic infection caused 
by intracellular bacteria of the genus Brucella, and 
Brucella melitensis is the most prevalent strain. It 
affects both humans and animals, and causes eco-
nomic cost and significant public health problems in 
many countries. Brucellosis is an endemic disease 
in Turkey. It is especially common in the middle and 
southeastern regions of our country [1].
It is generally a disease seen in young people 
and adults; it is less commonly seen in children and 
elderly. There are no specific clinical symptoms for 
brucellosis. It affects especially lymphoreticular sys-
tem organs (liver, bone marrow, spleen, and lymph 
nodes) and rarely heart, genitourinary system or-
gans, central nerve system [2,3].
Human brucellosis is a systemic disease and 
patients  with  brucellosis  have  nonspecific  symp-
toms and they have in a high risk of complications. 
The most frequent clinical symptoms are chill, in-
termittent fever, night sweating and joint pain. Fe-
ver occurs over 40ºC and causes miscarriages in 
pregnant  women.  Infertility  can  occur  in  result  of 
orchids in men [4,5]. Joint symptoms of brucellosis 
are  arthritis,  arthralgia,  sacroiliitis  and  spondylitis 
due to vertebral stiffness. Gastrointestinal, skeletal, 
and genitourinary findings are common but neuro-
brucellosis, pericarditis, and pancytopenia are rare 
complications of brucellosis. If the disease is not di-
agnosis early and not consider the differential diag-
nosis, the treatment chance will be missed. Some-
times, the disease can result in death because of 
its serious complications; infective endocarditis and 
meningoencephalitis [2-4].
Several approaches were used for treatment of 
brucellosis.  Doxycycline  and  streptomycin  combi-
nation or rifampicin and trimethoprim-sulfamethox-
azole combination can be used in treatment of this 
disease. Another choice is the combination of rifam-
picin with ofloxacin [6].
The aim of our study was to emphasize the de-
mographic,  epidemiological,  clinical,  occupational 
structures  and  seasonal  patterns  and  laboratory 
features of 541 brucellosis patients, and their out-
comes, during a 2-year period in the endemic re-
gion of Siirt in Southeastern Anatolia.
METHODS
We evaluated 1210 hospitalized patients retrospec-
tively between the dates of January 2006-Decem-
ber 2010 in Siirt General Hospital and 541 brucel-
losis cases were reviewed. Patients with Rose Ben-
gal plate test positive and has Wright agglutination 
test a titer of 1/160 or higher were included in the 
present study.
Wright tube agglutination test was performed 
according to the recommendations of the manufac-
turer (Seromed, Turkey). The sera were tested in 
dilutions of 1/40, 1/80, 1/160, 1/320, 1/640, 1/1280, 
and 1/2560; and titers of 1/160 and over were ac-
cepted as positive for brucellosis.Rose Bengal test 
was performed with slide agglutination method. The 
sera  were  treated  with  Sero-Lam  Brusella  Rose 
Bengal Plate Test (Seromed, Turkey) as described 
by the manufacturer and observation of agglutina-
tion on the slide were accepted as presence of the 
brucella antibodies and evaluated as positive for the 
disease.
The  data  received  from  the  patient’s  files  in 
clinic  archive. Age,  gender,  occupation,  seasonal 
specifications of the disease, duration of symptoms 
at admission, history of drinking of raw milk, eat-
ing of milk products, clinical symptoms, results of 
physical  examination  and  laboratory  results  were 
recorded.
 “Detection of Rose Bengal test positives and 
a  titer  of  1/160  or  higher  of  Wright  agglutination 
test” or “Reproduction of Brucella bacteria in any 
culture” was used for diagnosis criteria with clinical 
symptoms such as arthralgia, fever, sweating, chills, 
headache, and malaise. 
Statistical analysis:  Data  analysis  was  per-
formed using the SPSS software (ver. 15.0 for Win-
dows; SPSS Inc., Chicago, IL). Data are shown as 
means  ±  standard  deviations  or  medians,  where 
appropriate. Descriptive statistics are expressed as 
numbers and percentages. 
RESULTS
A  53.6%  of  patients  were  male  and  46.4%  were 
female.  The  mean  age  of  brucellosis  cases  was 
41.23±2.7 years. Brucellosis found most commonly 
in both men and women between 31 and 50 years 
of ages.
Hematological  evidence  discovered  that  for 
67%  of  patients  sedimentation  were  20-40  mm/
hour,  27%  of  patients  sedimentation  were  40-70 
mm/hour, 54% leukocyte count of the patients were 
between normal range (5,000-10,000/mm3), 36% of 
patients had leukocytosis, 10% had leukopenia, 8% 
had thrombocytopenia and 14 % had anemia (Table 
1).
Most  commonly  three  symptoms  were;  joint 
pain 90%, myalgia 75% and weakness 70% (Table Demircan et al. Epidemiological data of patients with brucellosis 138
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2). The most involved systems were musculoskel-
etal 28%, hematological 22%, and gastrointestinal 
systems  20%.  Most  commonly  systemic  findings 
were  sacroiliitis  20%  of  skeletal  system,  anemia 
14% of hematological symptoms and liver dysfunc-
tion 12% of gastrointestinal system (Table 3).
The  average  hospitalization  time  of  cases  is 
approximately 6.2±1.3 days, which comprises the 
time for acquiring test results and initial treatment.
Distributions of patients according to their oc-
cupation were shown in Table 4. The majority of 
the cases occupational group was agriculture and 
stockbreeding 47%. Housewives 33% were ranked 
second. The month in which majority of the cases 
(30% of patients) applying to hospital was May (Fig-
ure 1).
Bacteria were isolated in only 14 of 70 cultures 
of patients. Bone marrow culture was not obtained 
from any of the patients.
Figure 1. Distribution of cas-
es  according  to  application 
months 
Table 1. Laboratory findings of patients
Laboratory findings n (%)
Erythrocyte Sedimentation Rate (41-70 mm/h) 148 (27)
Erythrocyte Sedimentation Rate (21-40 mm/h) 364 (67)
Erythrocyte Sedimentation Rate (1-20 mm/h) 29 (5)
The Number of leukocyte (>10,000/mm3) 198 (37)
The Number of leukocyte (5,000-10,000/mm3) 287 (53)
The Number of leukocyte (<5,000/mm3) 56 (10)
Anemia (Hb <12 mg/dL) 78 (14)
Thrombocytopenia (<100,000/mm3) 44 (8)
ALT (>50 IU/ml) 67 (12)
Rose Bengal positivity 541 (100)
Wright agglutination positivity 541 (100)
Isolation from blood culture 14 (20)
Table 2. Clinical signs and findings of patients
Clinical signs and findings n (%)
Joint pain 487 (90)
Myalgia 403 (75)
Weakness 380 (70)
Fever (>38°C) 334 (61)
Night sweats 286 (53)
Splenomegaly 60 (11)
Hepatomegaly 56 (10)
Lymphadenopathy 54 (10)
Abdominal pain 23 (4)
Table 3. Systemic involvement of patients
System involvement n (%)
Musculoskeletal involvement 151 (28)
Sacroiliitis 104 (19)
Peripheral arthritis 42 (8)
Spondylitis 5 (1)
Gastrointestinal involvement 113 (21)
Hepatitis 67 (12)
Vomiting 35 (7)
Diarrhea 11 (2)
Hematological system involvement 122 (23)
Thrombocytopenia (<100,000/mm3) 44 (8)
Anemia (<12 mg/dL) 78 (15)
Genitourinary system involvement 3 (1)
Epididymo-orchitis 3 (1)
Neurological system involvement 0
Dermatological system involvement 0Demircan et al. Epidemiological data of patients with brucellosis 139
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Table 4. The distribution of patients according to the oc-
cupation
Job n (%)
Agriculture and animal husbandry 256 (47)
Housewife 182 (34)
Student 62 (12)
Self-employed 14 (2.5)
Officer 14 (2.5)
Pensioner 13 (2)
DISCUSSION
Brucellosis is a zoonotic infection and isolates from 
commonly in animals such as goat and sheep. It 
is not eradicated completely from the world. Every 
year 500 thousand recent brucellosis cases occur 
on the world, and the occurrence rate in our coun-
try was found between 1% and 26.7%, depending 
on the region [5-6]. Brucellosis is a systemic infec-
tion disease and it has very heterogeneous clinical 
spectrum. Varying in spectrum between light form 
and lethal forms and symptoms and signs in clinical 
charts are not always original. Nonspecific symp-
toms are usually observed such as fever, exhaus-
tion,  sweating,  and  myalgia. The  prevalence  and 
pattern of symptoms and clinical findings depend 
on age of patient, individual immune response and 
duration of disease [7].
In  our  country  brucellosis  is  commonly  ob-
served in Eastern and Southeastern Anatolia [8,9]. 
Cheese with added herbs is produced in provinces 
of Van, Diyarbakır, Bitlis, Siirt, Batman, Kars, and 
Hakkari. Brucellosis rate increases in these regions 
because of not boiling the milk enough or not being 
pasteurized [10,11].
Production  of  cheese  with  added  herbs  and 
sheep’s milk increase on April, May, and June espe-
cially. This condition explains why brucellosis cases 
increase especially during spring months. Accord-
ing to epidemiological data of 2005 by the Republic 
of Turkey Ministry of Health, morbidity rate of bru-
cellosis was one in 100,000 until the 1980’s and it 
was increased gradually in later years. Then it was 
20.3 in 100,000 in year 2005 [12].
In our country primary symptoms were found to 
be fever 43-83%, night sweating 69%, lumbar pain 
22-33%,  headache  28-44%,  lack  of  appetite  34-
53%, joint pain 20-76%, myalgia 56%, exhaustion 
14-81%, gait disorder 11-18%, mental confusion 6% 
and weight loss 2-36%. Our results were similar to 
previous studies [13].
In brucellosis musculoskeletal system is gener-
ally the most involved system and its involvement 
rate  is  14-49%  [14,15].  Musculoskeletal  involve-
ment is determined to be 28% in our patients.
Frequent  involvement  of  reticuloendothelial 
system organs such as liver and spleen in brucel-
losis can be observed. Insignificant elevated trans-
aminases can be seen depending on hepatospleno-
megaly. These elevated transaminases usually do 
not require treatment. In 12% of our patients, serum 
transaminases were determined above the normal 
range, 10% has hepatomegaly, and 9% has sple-
nomegaly. They didn’t need any treatment. In some 
patients with elevated serum transaminases, eleva-
tion  could  be  depending  on  antibiotics  and  anal-
gesics which used in threatment. Therefore serum 
transaminase  should  be  followed  up  regularly  to 
protect hepatotoxic effects of tetracycline and rifam-
picin under.
Hematological variety is common in brucellosis, 
however they don’t have diagnostic character and 
usually they don’t require therapy. Leukocyte levels 
are generally normal or decrease in brucellosis. In 
our study, leukocyte levels are in range of 4,000-
10,000/mm3 in 53% of patients, 36% of patients had 
leukocytosis, 10% had leukopenia. In other studies 
about the subject, similar results are obtained [15]. 
Thrombocytopenia and anemia are seen in brucel-
losis; however, they don’t require therapy: In our 
study,  8%  of  the  patients  had  thrombocytopenia 
≤100,000/mm3 and 14% had anemia (Hb <12g/dL) 
.They didn’t need any treatment.
Dermatological symptoms and signs are rare 
complications in brucellosis and they were not seen 
in our patients. Neurological findings are uncommon 
but life-threatening complications of brucellosis. In-
cidence of neurological manifestation are between 
the  ranges  of  0-25%  in  previous  studies  [15,16]. 
These different results are due to diagnostic meth-
ods  and  difference  between  case  definitions.  No 
neurobrucellosis case was observed in our study.
Occupation distribution of brucellosis patients 
were also examined in the present study, the high-
est rated occupational groups are found to be oc-
cupied in agriculture and stockbreeding. Similar re-
sult is obtained in previous studies from Turkey that 
supporting conventional data [17].
Blood cultures were taken from 70 patients; re-
production was observed only fourteen of the cul-
tures. In our country, culture positives are found to 
be 12-70% [15,18,19], this rate is between 72-84% 
in international studies. The difference is related to 
antibiotics therapy before taking blood culture. This Demircan et al. Epidemiological data of patients with brucellosis 140
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condition  decrease  culture  positives  rate  [20,21]. 
One of the reasons of lowered culture positives in 
our and our country’s studies is incompetence of 
laboratory practices and resources. The other im-
portant  reason  can  be  frequent  empiric  antibiotic 
administration to patients with fever.
Our country is an endemic region for brucello-
sis, diagnosis and treatment of the disease is very 
important. Despite the effort programs in our coun-
try, infection rate is still high and it affects both ani-
mal industry and human health.
We intended to examine this subject by offering 
our experiences  regarding  this preventable  infec-
tious disease that is significant for our country. Data 
about  this  common  systemic  infectious  disease 
should be supported with large multicenter studies, 
the personnel in first degree health service should 
be helped to become aware and the people should 
be educated about symptoms of the disease and 
ways of transmission.
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